EPS9.06 Development of levofloxacin resistance in clinical Pseudomonas aeruginosa isolates from people with cystic fibrosis in an in vitro variable exposure model

C.M. Sloan; L.J.  Sherrard; G.G.  Einarsson; M.M.  Tunney; D.G.  Downey

doi:10.1016/S1569-1993(23)00372-7

EPS9.06 Development of levofloxacin resistance in clinical Pseudomonas aeruginosa isolates from people with cystic fibrosis in an in vitro variable exposure model

C.M. Sloan, L.J. Sherrard, G.G. Einarsson, M.M. Tunney, D.G. Downey

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	S62
Number of pages	1
Journal	Journal of Cystic Fibrosis
Volume	22
Issue number	Supplement 2
DOIs	https://doi.org/10.1016/S1569-1993(23)00372-7
Publication status	Published - 01 Jun 2023
Event	46th European Cystic Fibrosis Conference - Vienna, Austria Duration: 07 Jun 2023 → 10 Jun 2023

Access to Document

10.1016/S1569-1993(23)00372-7Licence: Unspecified

Cite this

@article{2fe0c49ec21e468d9adb6f17b9d3b5c3,

title = "EPS9.06 Development of levofloxacin resistance in clinical Pseudomonas aeruginosa isolates from people with cystic fibrosis in an in vitro variable exposure model",

author = "C.M. Sloan and L.J. Sherrard and G.G. Einarsson and M.M. Tunney and D.G. Downey",

year = "2023",

month = jun,

day = "1",

doi = "10.1016/S1569-1993(23)00372-7",

language = "English",

volume = "22 ",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier Inc.",

number = "Supplement 2",

note = "46th European Cystic Fibrosis Conference ; Conference date: 07-06-2023 Through 10-06-2023",

}

EPS9.06 Development of levofloxacin resistance in clinical Pseudomonas aeruginosa isolates from people with cystic fibrosis in an in vitro variable exposure model. / Sloan, C.M.; Sherrard, L.J. ; Einarsson, G.G. et al.

In: Journal of Cystic Fibrosis, Vol. 22 , No. Supplement 2, S62, 01.06.2023.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - EPS9.06 Development of levofloxacin resistance in clinical Pseudomonas aeruginosa isolates from people with cystic fibrosis in an in vitro variable exposure model

AU - Sloan, C.M.

AU - Sherrard, L.J.

AU - Einarsson, G.G.

AU - Tunney, M.M.

AU - Downey, D.G.

PY - 2023/6/1

Y1 - 2023/6/1

U2 - 10.1016/S1569-1993(23)00372-7

DO - 10.1016/S1569-1993(23)00372-7

M3 - Meeting abstract

VL - 22

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

SN - 1569-1993

IS - Supplement 2

M1 - S62

T2 - 46th European Cystic Fibrosis Conference

Y2 - 7 June 2023 through 10 June 2023

ER -

EPS9.06 Development of levofloxacin resistance in clinical Pseudomonas aeruginosa isolates from people with cystic fibrosis in an in vitro variable exposure model

Access to Document

Fingerprint

Cite this